Skip to main content
. 2013 Nov;57(11):5423–5425. doi: 10.1128/AAC.00039-13

Fig 1.

Fig 1

(A) Efficacy of DAV131 in adsorbing CTX residues in the colon. The CTX concentrations in feces (μg/100 mg of feces) during treatment (D−2 to D0) are shown. The vertical bars represent 95% CI. (B) Efficacy of DAV131 in reducing CTX-induced colonization by K. pneumoniae strain PUG-2. The densities (log10 CFU/g of feces) of PUG-2 after orogastric challenge with 106 CFU of PUG-2 on day 0 are shown. Prior to inoculation, none of the mice had detectable levels of PUG-2 (level of detection, ∼3 log10 CFU/g of feces). The whiskers represent 95% CI.